Arbutus Biopharma Corporation (Nasdaq: ABUS), a key player in advancing treatments for chronic hepatitis B (cHBV), outlined ...

According to the Hepatitis B Foundation, up to 2.4 million people in the United States are living with chronic hepatitis B ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...

Viral hepatitis is a common disease globally, but many are unaware of their status. Symptoms and transmission routes are discussed here.

Excision announces publication highlighting EBT-107 for treatment of chronic hepatitis B in bioRxiv: Watertown, Massachusetts Friday, May 16, 2025, 18:00 Hrs [IST] Excision BioThe ...

From Deepika Kakkar's liver tumor to Sonali Bendre's cancer, several celebrities have battled serious illnesses. Learn about ...

Precision BioSciences, Inc.’s DTIL share price has dipped by 9.90%, which has investors questioning if this is right time to ...

Hepatitis A may not be on your radar, but with the current LA County outbreak, you may want to reacquaint yourself with this ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

Current therapies for chronic hepatitis B virus (HBV) infection can effectively suppress viral replication but do not achieve ...

Issue: Whether the U.S. Court of Appeals for the 5th Circuit erred in holding that the structure of the U.S. Preventive Services Task Force violates the Constitution's appointments clause and in ...